Why the study?
Is there an abnormality of pituitary-adrenal function in massively obese patients with acanthosis nigricans compared to those without?
Is there an abnormality of pituitary-adrenal function in massively obese patients with acanthosis nigricans compared to those without?
Massively obese patients have high baseline adrenocortical function, but acanthosis nigricans itself is not associated with specific pituitary-adrenal abnormalities except in a subset of females with hirsutism and menstrual irregularities.
Acanthosis nigricans does not confer specific pituitary-adrenal abnormalities beyond obesity; leaves open targeted evaluation in females with hirsutism.
Historical findings, physical characteristics, and results of laboratory evaluation of adrenocortical function were studied in 14 massively obese patients with benign acanthosis nigricans and a comparably obese group of 14 patients without the skin lesion. The baseline level of adrenocortical function was high in both groups as compared with normal controls, and there was a tendency to hyperresponsiveness to corticotropin (adrenocorticotropic hormone). Urinary 17-ketogenic steroids were suppressed poorly by the administration of dexamethasone, regardless of whether the patient did or did not have acanthosis. In striking contrast, there was normal suppression of 17-hydroxycorticosteroids (Porter-Silber chromogens) in response to dexamethasone in every patient. Except for four female patients with acanthosis, hirsutism, menstrual irregularities, and loss of the diurnal variation in plasma levels of 11-hydroxycorticosteroids, there was no abnormality of pituitary-adrenal function in massively obese patients with or without acanthosis nigricans.
No takes yet. Share an insight, caveat, or question.
Dorothy R. Hollingsworth (1969) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: